Skip to content

Electrical Stimulation to Promote Recovery in Bells Palsy

Pilot Clinical Trial to Study Facial Electrical Stimulation to Promote Recovery in Patients With Bell's Palsy and Poor Prognostic Factors

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03836989
Enrollment
4
Registered
2019-02-11
Start date
2018-01-22
Completion date
2020-08-31
Last updated
2021-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell Palsy

Keywords

Facial Paralysis, Bell Palsy, Electrical Stimulation

Brief summary

A feasibility pilot study to exam the necessary methodology for conducting a larger clinical trial for Bell's Palsy patients with a poor prognosis and the use of electrical stimulation.

Detailed description

Here we describe a protocol for a prospective, randomized, double-blinded study to evaluate the effects of monophasic pulsed current ES on patients with Bell's palsy and factors predicting poor recovery, with a 6 month follow up. Motor level stimulation with a pulse duration of 100 μsec and a frequency of 35 pulses per second were chosen from focus group with physical therapist to treat facial paralysis and are consistent with clinical trials showing motor benefit after capel tunnel surgery.

Interventions

DEVICEElectrical stimulation device (tens unit)

An electrical stimulation device with adjustable voltage. Useful for both Sensory and Subsensory

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Investigator and outcome assessors are blinded to the intervention. The physical therapist that teaches the research subjects how to perform the interventions are not blinded and patients are told they are assigned to either sensory or subsensory protocols.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* New diagnosis of bell's palsy (diagnosed in the last 30 days) * IF younger than 60 years of age must have complete paralysis on one side of face or both * IF older than 60 years of age paralysis must be present but CAN be incomplete.

Exclusion criteria

* Paralysis associated with any of the fallowing: cancer, tumor, surgery, stroke, or trauma. * Younger than 60 years old with INCOMPLETE paralysis. * Non English speakers * Pacemaker or deep brain stimulator

Design outcomes

Primary

MeasureTime frameDescription
Recovery at 3 Months as Measured From Facial Photos With Different Facial Expressions3 monthsTo evaluate for complete recovery, standardized photos of patients at rest, and during movement, will be evaluated by three treatment-blinded otolaryngologists. Total number of patients fully recovered over number of participants will be reported.

Secondary

MeasureTime frameDescription
Patient Reported Quality of Life in Relation to Facial Synkinesis Measured by the Synkinesis Assessment Questionnaire (SAQ)Baseline, 3 months and 6 monthsQuality of life is in part measured in this study using the patient reported Synkinesis Assessment Questionnaire (SAQ). The instrument consisting of 10 items asks participants how difficult certain facial activities are. Based on the average score for each domain the test gives a score between 20 (no synkinesis) to 100 (severe synkinesis, all the time).
Patient Reported Global Quality of Life Specific to Facial ParalysisBaseline, 3 months and 6 monthsMeasured by the validated quality of life patient reported questionnaire Facial Clinimetric Evaluation (FaCE) Scale with a scale from 0 (normal) to 100 (severe dysfunction). The scale encompasses facial movement, facial comfort, oral function, eye comfort, lacrimal control, and social function.
Objective Measurements of Brow ElevationBaseline and in 3 monthsMeasuring brow elevation using the MEEI FACE-gram program reported as the millimeters in decreased elevation in comparison to the unaffected side
Eye ClosureBaseline and 3 monthsMeasuring in millimeters of the eyelids remaining open during maximal eye closure using the MEEI FACE-gram program
House Brackmann ScaleBaseline, and 3 monthsDetermined by three blinded otolaryngologist reviewing facial photos of patients with smile and eye closure. Reported as an average of the three scores. The scales ranges from 1 (normal) to 6 (most severe dysfunction)
Facial Symmetry at RestBaseline and 3 monthsMeasured by facial asymmetry index (FAI) at rest in photos which is calculated as the difference in the distance from the lateral canthus to the oral commissure between the affected and unaffected side. In the scale 0 equals no difference between sides and perfect symmetry. The closer a number is to 0, the higher the symmetry is. Ranges have not been published for this scale. FAI does not have a maximum score.
Facial Symmetry During SmileBaseline and 3 monthsMeasured by facial asymmetry index (FAI) during smile in photos which is calculated as the difference in the distance from the lateral canthus to the oral commissure between the affected and unaffected side. In the scale 0 equals perfect symmetry and no difference in sides. The closer a number is to 0, the greater the symmetry. Ranges have not been published for this scale. FAI does not have a maximum score.
Patient Tolerability3 monthsMeasured by a visual analog scale (VAS) which ranged from 0 to 10 where 0 stands for completely comfortable and 10 to very uncomfortable. A questionnaire designed by research team using a Likert's scale was created to measure patient tolerability.
Self Reported Subject Adherence3 monthsPercentage of subjected who reported full adherence, partial adherence and non-adherence confirmed by comparing to the daily diary of use.
Smile ExcursionBaseline and 3 monthsMeasuring oral commissure exclusion using the MEEI FACE-gram program reported as the change in millimeters in the distance between the midline of the lower lip and the oral commissure in comparison between rest and smile

Countries

United States

Participant flow

Pre-assignment details

Blocks were designed to account for predictors of recovery. There were four allocation blocks: 1) \>60 age with complete paralysis, 2) \> 60 age with incomplete paralysis, 3) \<60 age with complete paralysis and \< 15 days duration, or 4) \<60 age with complete paralysis and \>15 days duration. The block size was 2 and the allocation was 1:1. All patients were randomly allocated to high-volt arm

Participants by arm

ArmCount
High-volt Electrical Stimulation
Plan to use a monophasic waveform having 100µmsec pulse duration, at 35 Hz using tolerated voltage to generate a contraction a total of 20 minutes. The stimulation will have 10 seconds on time, 30 seconds off time and 2 second ramp up and down. Electrical stimulation will be produced with the Orthostim 3 device (VQ Ortho Care). The cathode will be placed on the ipsilateral muscle to stimulate and the anode over the ipsilateral mastoid region. Four facial muscles will be stimulated: 1)frontalis, 2) orbicularis oculi, 3) zygomaticus major, and 4) orbicularis oris. The voltage is turned up by the participant until he or she can see twitches or as high as tolerated. Ten contractions in each muscle group will be performed or 5 minutes per muscle if no contraction is achieved
4
Subsensory Electrical Stimulation
Plan to use the same device and settings to provide placebo treatment by delivering minimal electricity. The settings will be the same as the intervention except the voltage will be subsensory. ie. below the minimum at which patients feels any effect of the current. The voltage is turned down two clicks from the voltage at which the participant can first notice any electricity or at the minimal setting.
0
Total4

Baseline characteristics

CharacteristicTotalHigh-volt Electrical Stimulation
Age, Categorical
<=18 years
0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants2 Participants
Age, Categorical
Between 18 and 65 years
2 Participants2 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
4 Participants4 Participants
Sex: Female, Male
Female
3 Participants3 Participants
Sex: Female, Male
Male
1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 40 / 0
other
Total, other adverse events
3 / 40 / 0
serious
Total, serious adverse events
0 / 40 / 0

Outcome results

Primary

Recovery at 3 Months as Measured From Facial Photos With Different Facial Expressions

To evaluate for complete recovery, standardized photos of patients at rest, and during movement, will be evaluated by three treatment-blinded otolaryngologists. Total number of patients fully recovered over number of participants will be reported.

Time frame: 3 months

Population: Randomization led to no Subsensory participants.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
High-volt Electrical StimulationRecovery at 3 Months as Measured From Facial Photos With Different Facial Expressions3 Participants
Secondary

Eye Closure

Measuring in millimeters of the eyelids remaining open during maximal eye closure using the MEEI FACE-gram program

Time frame: Baseline and 3 months

Population: No subjects were allocated to the subsensory arm

ArmMeasureGroupValue (MEAN)Dispersion
High-volt Electrical StimulationEye ClosureBaseline2.5 millimetersStandard Deviation 3.1
High-volt Electrical StimulationEye Closure3 months0.5 millimetersStandard Deviation 0.6
Secondary

Facial Symmetry at Rest

Measured by facial asymmetry index (FAI) at rest in photos which is calculated as the difference in the distance from the lateral canthus to the oral commissure between the affected and unaffected side. In the scale 0 equals no difference between sides and perfect symmetry. The closer a number is to 0, the higher the symmetry is. Ranges have not been published for this scale. FAI does not have a maximum score.

Time frame: Baseline and 3 months

Population: No subjects were allocated to the subsensory arm

ArmMeasureGroupValue (MEAN)Dispersion
High-volt Electrical StimulationFacial Symmetry at RestBaseline0.25 score on a scaleStandard Deviation 0.2
High-volt Electrical StimulationFacial Symmetry at Rest3 months0.02 score on a scaleStandard Deviation 0
Secondary

Facial Symmetry During Smile

Measured by facial asymmetry index (FAI) during smile in photos which is calculated as the difference in the distance from the lateral canthus to the oral commissure between the affected and unaffected side. In the scale 0 equals perfect symmetry and no difference in sides. The closer a number is to 0, the greater the symmetry. Ranges have not been published for this scale. FAI does not have a maximum score.

Time frame: Baseline and 3 months

Population: no subjects were allocated to the subsensory arm

ArmMeasureGroupValue (MEAN)Dispersion
High-volt Electrical StimulationFacial Symmetry During SmileBaseline0.4 score on a scaleStandard Deviation 0.6
High-volt Electrical StimulationFacial Symmetry During Smile3 months0.2 score on a scaleStandard Deviation 0.19
Secondary

House Brackmann Scale

Determined by three blinded otolaryngologist reviewing facial photos of patients with smile and eye closure. Reported as an average of the three scores. The scales ranges from 1 (normal) to 6 (most severe dysfunction)

Time frame: Baseline, and 3 months

Population: No subjects underwent subsensory electrical stimulation

ArmMeasureGroupValue (MEAN)Dispersion
High-volt Electrical StimulationHouse Brackmann Scale3 months2 score on a scaleStandard Deviation 1.15
High-volt Electrical StimulationHouse Brackmann ScaleBaseline5.5 score on a scaleStandard Deviation 1
Secondary

Objective Measurements of Brow Elevation

Measuring brow elevation using the MEEI FACE-gram program reported as the millimeters in decreased elevation in comparison to the unaffected side

Time frame: Baseline and in 3 months

Population: No subjects were allocated to the subsensory arm

ArmMeasureGroupValue (MEAN)Dispersion
High-volt Electrical StimulationObjective Measurements of Brow ElevationBaseline7.75 millimetersStandard Deviation 2.2
High-volt Electrical StimulationObjective Measurements of Brow Elevation3 months4.5 millimetersStandard Deviation 5.2
Secondary

Patient Reported Global Quality of Life Specific to Facial Paralysis

Measured by the validated quality of life patient reported questionnaire Facial Clinimetric Evaluation (FaCE) Scale with a scale from 0 (normal) to 100 (severe dysfunction). The scale encompasses facial movement, facial comfort, oral function, eye comfort, lacrimal control, and social function.

Time frame: Baseline, 3 months and 6 months

Population: No subjects were recruited for the subsensory arm

ArmMeasureGroupValue (MEAN)Dispersion
High-volt Electrical StimulationPatient Reported Global Quality of Life Specific to Facial ParalysisBaseline37.5 score on a scaleStandard Deviation 3.4
High-volt Electrical StimulationPatient Reported Global Quality of Life Specific to Facial Paralysis3 months51.25 score on a scaleStandard Deviation 12.03
High-volt Electrical StimulationPatient Reported Global Quality of Life Specific to Facial Paralysis6 months51 score on a scaleStandard Deviation 15
Secondary

Patient Reported Quality of Life in Relation to Facial Synkinesis Measured by the Synkinesis Assessment Questionnaire (SAQ)

Quality of life is in part measured in this study using the patient reported Synkinesis Assessment Questionnaire (SAQ). The instrument consisting of 10 items asks participants how difficult certain facial activities are. Based on the average score for each domain the test gives a score between 20 (no synkinesis) to 100 (severe synkinesis, all the time).

Time frame: Baseline, 3 months and 6 months

Population: No research subjects participated in the subsensory electrical stimulation arm

ArmMeasureGroupValue (MEAN)Dispersion
High-volt Electrical StimulationPatient Reported Quality of Life in Relation to Facial Synkinesis Measured by the Synkinesis Assessment Questionnaire (SAQ)3 month outcome27.5 score on a scaleStandard Deviation 5.25
High-volt Electrical StimulationPatient Reported Quality of Life in Relation to Facial Synkinesis Measured by the Synkinesis Assessment Questionnaire (SAQ)6 month outcome38.7 score on a scaleStandard Deviation 23.5
High-volt Electrical StimulationPatient Reported Quality of Life in Relation to Facial Synkinesis Measured by the Synkinesis Assessment Questionnaire (SAQ)Baseline31 score on a scaleStandard Deviation 7.7
Secondary

Patient Tolerability

Measured by a visual analog scale (VAS) which ranged from 0 to 10 where 0 stands for completely comfortable and 10 to very uncomfortable. A questionnaire designed by research team using a Likert's scale was created to measure patient tolerability.

Time frame: 3 months

Population: No subjected were recruited for the subsensory arm

ArmMeasureValue (MEAN)Dispersion
High-volt Electrical StimulationPatient Tolerability2.7 score on a scaleStandard Deviation 2.3
Secondary

Self Reported Subject Adherence

Percentage of subjected who reported full adherence, partial adherence and non-adherence confirmed by comparing to the daily diary of use.

Time frame: 3 months

Population: no subjects were recruited to the subsensory electrical stimulation

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
High-volt Electrical StimulationSelf Reported Subject AdherenceNon adherence0 Participants
High-volt Electrical StimulationSelf Reported Subject AdherenceFull adherence4 Participants
High-volt Electrical StimulationSelf Reported Subject AdherencePartial adherence0 Participants
Secondary

Smile Excursion

Measuring oral commissure exclusion using the MEEI FACE-gram program reported as the change in millimeters in the distance between the midline of the lower lip and the oral commissure in comparison between rest and smile

Time frame: Baseline and 3 months

Population: No subjects were allocated to the subsensory arm

ArmMeasureGroupValue (MEAN)Dispersion
High-volt Electrical StimulationSmile ExcursionBaseline-1 millimetersStandard Deviation 1.15
High-volt Electrical StimulationSmile Excursion3 months4.5 millimetersStandard Deviation 3.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026